Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol K Kasper

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Seminars in Thrombosis and Hemostasis|November 9, 2005
Products for clotting factor replacement in developing countriesCarol K Kasper
Seminars in Thrombosis and Hemostasis|January 14, 2004
Advances in care of children with hemophiliaMarilyn J Manco-Johnson, Brenda Riske, Carol K Kasper
Blood|November 20, 2014
The intron-22-inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomicsZuben E Sauna, Jay N Lozier, Carol K Kasper, et al.
The New England Journal of Medicine|April 17, 2009
Inhibitors of factor VIII in black patients with hemophiliaKevin R Viel, Afshin Ameri, Thomas C Abshire, et al.
Genes and Immunity|April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Seminars in Thrombosis and Hemostasis|November 9, 2005
Products for clotting factor replacement in developing countriesCarol K Kasper
Seminars in Thrombosis and Hemostasis|January 14, 2004
Advances in care of children with hemophiliaMarilyn J Manco-Johnson, Brenda Riske, Carol K Kasper
Blood|November 20, 2014
The intron-22-inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomicsZuben E Sauna, Jay N Lozier, Carol K Kasper, et al.
The New England Journal of Medicine|April 17, 2009
Inhibitors of factor VIII in black patients with hemophiliaKevin R Viel, Afshin Ameri, Thomas C Abshire, et al.
Genes and Immunity|April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Pageof 1